US Productivity Growth Slows in Q4 as Unit Labor Costs Rise Signaling Potential Inflationary Pressures Oil Prices Surge 3 as TrumpIran Tensions Raise Strait of Hormuz Risk Premium EU Chamber of Commerce Survey Signals Rebound in Business Confidence in China Chevron CVX Price Target Increased by 2 at Morgan Stanley Analyst Sentiment Suggests Modest Upside Deere Company Raises Outlook Highlighting Technology and AI as Growth Drivers Jardine Matheson Acquires Australian Imaging Firm IMED in 31 Billion Deal LeonaBio Inc LONA Q1 2026 Earnings EPS Surprise Provides Bright Spot Amid Revenue Absence and Stock Decline BTU Q1 2026 Earnings Missed EPS Estimates Amid Challenging Coal Market Hanover Bancorp Inc HNVR Q1 2026 Earnings Slight EPS Miss Despite Solid Operational Results DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals Garrett Motion Inc GTX Q1 2026 Earnings EPS Surpasses Estimates Driven by Operational Strength OSBC Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher KKR Real Estate Finance Trust KREF Gains 145 as Price Approaches Resistance United Homes Group Warrants UHGWW Hold Steady Near Key Support A RangeBound Stalemate Farmer Brothers Co FARM Holds Steady at 128 Amidst Key Technical Levels Insight Digital Partners II DYOR Edges Higher Near Resistance on Minimal Price Action Crexendo Inc CXDO Holds Steady Near Resistance as Volume Patterns Signal Cautious Optimism UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potentially Reshaping Platform Regulations MRDN Q1 2026 Earnings Massive EPS Beat with 107647 Surprise Leggett Platt LEG Slips 05 Approaches Critical Support as Downtrend Persists Nuvalent Inc NUVL Q1 2026 Earnings PreRevenue Biotech Narrows Operating Loss Stock Edges higher VUZI Q1 2026 Earnings EPS Beat but Revenue Uncertainty Lingers BFLY Q1 2026 Earnings EPS Beat Surprises as Butterfly Network Posts Narrower Loss KNOT Offshore Partners Q4 2025 Earnings Significant Earnings Miss Highlights Operational Challenges URBN Q1 2026 Earnings EPS Surges Past Estimates but Stock Dips Slightly REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs MSFT Q1 2026 Earnings EPS Surpasses Estimates but Stock Slightly Down